Phase 2 Study of Efficacy, Safety and Tolerability of R05186582 in Adults with Adolescents with Down Syndrome (Clematis)
Clinical Trial Grant
Awarded By
F. Hoffmann-La Roche Ltd
Start Date
April 15, 2014
End Date
April 14, 2016
Awarded By
F. Hoffmann-La Roche Ltd
Start Date
April 15, 2014
End Date
April 14, 2016